The In-vitro Diagnostics Market is expected to reach $141.65 billion by 2030, at a CAGR of 5.7% during the forecast period 2023–2030. The increasing global prevalence of chronic and infectious diseases coupled with the rising geriatric population, growing awareness for early disease diagnosis, a shift in the focus from centralized to the point of care testing, and the emergence of the COVID-19 pandemic are the key factors driving the growth of the IVD market. In addition, emerging economies, technological advancements, and advances in genomics and proteomics offer significant growth opportunities for the players operating in this market.
Impact of COVID-19 on In-vitro Diagnostics Market
The outbreak of the COVID-19 pandemic has positively impacted the market as the volume of testing significantly increased amid the pandemic. Diagnostic testing became a valuable tool amid the pandemic. The pandemic led to the development of new kits and assays by key manufacturers. For instance, in August 2021, Becton, Dickinson and Company (U.S.) received the FDA’s Emergency Use Authorization (EUA) for the BD Veritor At-Home COVID-19 Test, a rapid antigen test that uses the Scanwell Health Mobile App to interpret and deliver reliable results in 15 minutes.
Furthermore, in November 2020, Beckman Coulter, Inc. (U.S.) launched the Access SARS-CoV-2 IgG II test, a semi-quantitative assay that measures a patient’s relative level of antibodies. In May 2020, ERBA Diagnostics Mannheim GmbH (Germany) launched its immunoassay-based kit—ErbaLisa COVID-19 ELISA kits to detect IgG and IgM antibodies to SARS-CoV-2. This kit allows qualitative and semi-quantitative detection of IgG and IgM antibodies. In February 2020, altona Diagnostics GmbH (Germany) launched the RealStar SARS-CoV-2 RT-PCR Kit 1.0 for detecting the coronavirus using PCR. Thus, the launch of newer diagnostic kits will result in the increased adoption of in-vitro diagnostics for the kits or the assay development, thereby providing lucrative opportunities for the in-vitro diagnostics market growth in the upcoming years.
Multiple diagnostic test manufacturers were developed and sold to facilitate testing outside laboratory settings in response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents. These simple test kits are based either on detecting proteins from the COVID-19 virus in respiratory samples (e.g., sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to infection. This is expected to spur the IVD market growth in the upcoming years.
Click here to: Get Free Sample Copy of this report
Key Findings of the Global IVD Market Study:
The Kits and Reagents Segment is Expected to Grow at the Highest CAGR During the Forecast Period
On the basis of product & solution, the kits & reagents segment is expected to grow with the fastest growth during the forecast period. Factors such as rising awareness of rapid POC tests and increasing use of IVD kits and reagents to diagnose diseases in less time and cost are supporting the market growth. In addition, the frequent use of assays & kits in the detection of various chronic diseases, commercial availability of a diverse range of reagents, and increasing demand for COVID-19 testing products are driving the growth of this segment.
Based on Application, the Infectious Disease Segment is Estimated to Dominate the IVD Market in 2023
The large share of this segment is mainly attributed to the rising prevalence of infectious diseases, the rising geriatric population, the growing demand for early disease diagnosis, and government efforts to improve the accessibility of diagnostic services toward infectious disease testing.
The OTC/Self-testing Segment is Expected to Grow at the Highest CAGR During the Forecast Period
OTC kits are generally at-home testing covering fertility testing, blood glucose monitoring, cholesterol testing, and infectious & chronic diseases testing. With home testing kits, patients can save time and money required for hospital/lab visits, as these tests can be performed at home, and results can be shared with physicians remotely. The large share of this segment can be attributed to the high demand for at-home testing and the high prevalence of diseases that require rapid and effective testing.
The Diagnostic Laboratories Segment is Estimated to Account for the Largest Share of the In-Vitro Diagnostics Market in 2023
The large share of this segment is primarily attributed to the rising laboratory automation, availability of well-equipped systems, lack of skilled labor, high prevalence of infectious diseases, and presence of supportive government initiatives.
Asia Pacific: Fastest Growing Regional Market
North America is estimated to account for the largest share of the IVD market in 2023, while Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of the Asia-Pacific IVD market are increasing investments by healthcare providers towards diagnostics infrastructure improvement, the growing burden of chronic and infectious diseases, the rising geriatric population, the growing accessibility to healthcare services, and the increasing number of hospitals & clinics.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years. The key players profiled in the global IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnostica (Brazil), Wiener Laboratorios SAIC (Argentina), Ortho-Clinical Diagnostics, Inc. (U.S.), Agilent Technologies Inc. (U.S.), and DiaSorin S.p.A. (Italy).
Scope of the Report:
In-vitro Diagnostics Market, by Product & Solutions
In-vitro Diagnostics Market, by Technology
In-vitro Diagnostics Market, by Application
In-vitro Diagnostics Market, by Diagnostic Approach
In-vitro Diagnostics Market, by End User
In-vitro Diagnostics Market, by Geography
Key questions answered in the report:
The global IVD market is segmented based on product & solution (reagents & kits, systems, and software & services) and a wide range of technologies (immunoassay/immunochemistry, biochemistry/clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation/hemostasis, urinalysis, and other technologies) offered by key companies to various end users, such as diagnostic laboratories, hospitals & clinics, home healthcare, and other end users. The global IVD market studied in this report involves the value analysis of various segments and sub-segments of in-vitro diagnostics at regional and country levels.
The global IVD market is projected to reach $141.65 billion by 2030, at a CAGR of 5.7% during the forecast period.
The kits and reagents segment is estimated to account for the largest share of the IVD market in 2023. Factors such as the high burden of diseases, the high adoption of rapid diagnostic test kits, and the presence of initiatives supporting early disease diagnosis are responsible for the fastest growth of the segment.
Based on the technology, the immunoassay/immunochemistry segment is projected to create more traction.
Based on application, the oncology segment is projected to create more traction during the forecast period due to the growing burden of cancer and rising demand for early cancer diagnosis.
Based on end user, the hospitals & clinics segment is projected to create more traction during the forecast period due to a large number of hospitalization due to various diseases, the rising geriatric population, increasing healthcare access & expenditure, and the rising prevalence of healthcare-associated infections (HAIs).
Rising prevalence of chronic and infectious diseases, growing awareness for early disease diagnosis, a shift in the focus from centralized to the point of care testing, and technological innovations. Further, emerging economies, the emergence of the COVID-19 pandemic, and advances in genomics and proteomics offer significant growth opportunities for the players operating in this market.
The key players operating in the global IVD market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Thermo Fisher Scientific (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Ortho Clinical Diagnostics (U.S.), Siemens Healthcare GmbH (Germany), Sysmex Corporation (Japan), and QIAGEN N.V. (Netherlands).
The emerging countries from Asia and Latin America are projected to offer significant growth opportunities for the vendors in this market due to rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, growing infectious diseases, and growing accessibility to healthcare services & advanced products.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for This Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Rising Prevalence of Acute and Chronic Infectious Diseases
4.2.3. Increasing Funding for Research Activities
4.2.4. Growing Awareness Regarding Early Disease Diagnosis
4.2.5. Growing Demand for Point-of-Care (POC) Diagnostics
4.2.6. Technological Innovation
4.3. Restraints
4.3.1. Unfavorable Reimbursement Scenario
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Inclination Towards Personalized Medicine
4.4.3. Advances in Genomics and Proteomics
4.5. Challenges
4.5.1. Evolving Regulatory Landscape
4.6. Impact of COVID-19 on the IVD Market
4.7. Pricing Analysis
4.8. Regulatory Affairs Analysis
4.9. In-Vitro Diagnostics: Innovations & Upcoming Technologies
5. Global In-Vitro Diagnostics (IVD) Market, By Product & Solution
5.1. Introduction
5.2. Reagents & Kits
5.3. Systems
5.4. Software & Services
6. Global In-Vitro Diagnostics (IVD) Market, By Technology
6.1 Introduction
6.2 Immunoassay/Immunochemistry
6.2.1 Enzyme-linked Immunosorbent Assays (ELISA)
6.2.2 Radioimmunoassay
6.2.3 Western Blotting
6.2.4 Enzyme-linked Immunospot Assays
6.2.5 Immunohistochemistry (IHC)
6.3 Biochemistry/Clinical Chemistry
6.3.1 Metabolic Panel
6.3.2 Electrolyte Panel
6.3.3 Liver Panel
6.3.4 Lipid Profile
6.3.5 Renal Profile
6.3.6 Thyroid Function Panel
6.4 Molecular Diagnostics
6.4.1 Polymerase Chain Reaction (PCR)
6.4.2 Isothermal Nucleic Acid Amplification Technology
6.4.3 Microarray
6.4.4 Hybridization
6.4.5 DNA Sequencing & Next-generation Sequencing
6.4.6. Mass Spectrometry
6.4.7. Others
6.5 Point of Care (POC) Diagnostics
6.5.1. Lateral Flow Assays/Rapid Tests
6.5.2. POC Molecular Diagnostics
6.5.3. Others
6.6 Whole Blood Glucose Monitoring
6.7 Microbiology
6.8 Hematology
6.9 Coagulation/Hemostasis
6.10 Urinalysis
6.11 Other Technologies
7. Global In-Vitro Diagnostics (IVD) Market, By Application
7.1 Introduction
7.2 Infectious Diseases
7.2.1 Respiratory Infections (Excluding Influenza)
7.2.2 Hepatitis Testing
7.2.3 HIV Testing
7.2.4 Tropical Diseases Testing
7.2.5 Influenza
7.2.6 Sexually Transmitted Diseases (STD) Testing
7.2.7 Other Infectious Diseases
7.3 Oncology
7.3.1 Breast Cancer
7.3.2 Lung Cancer
7.3.3 Colorectal and Gastrointestinal Cancers
7.3.4 Prostate Cancer
7.3.5 Other Cancers
7.4 Diabetes
7.5 Cardiology
7.6 Nephrology
7.7 Autoimmune Disorders
7.8 Other Applications
8. Global In-Vitro Diagnostics (IVD) Market, By Diagnostic Approach
8.1 Introduction
8.2 Lab Testing
8.3 OTC/Self-testing
8.4 Point of Care Testing
9. Global In-Vitro Diagnostics (IVD) Market, By End User
9.1 Introduction
9.2 Diagnostic Laboratories
9.3 Hospitals & Clinics
9.4 Home Healthcare
9.5 Other End Users
10. In-Vitro Diagnostics (IVD) Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Switzerland
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East
10.6.1 Saudi Arabia
10.6.2 Rest of Middle East
10.7 Africa
10.7.1 South Africa
10.7.2 Rest of Africa
11. Competitive Landscape
11.1 Introduction
11.2 Key Growth Strategies
11.3 Competitive Benchmarking
11.4 Market Share Analysis (2022)
12. Company Profiles
12.1 Abbott Laboratories
12.2 Agilent Technologies Inc.
12.3 Becton, Dickinson and Company
12.4 bioMérieux SA
12.5 Bio-Rad Laboratories, Inc.
12.6 Danaher Corporation
12.7 DiaSorin S.p.A.
12.8 F. Hoffmann-La Roche Ltd.
12.9 Illumina, Inc.
12.10 Ortho-Clinical Diagnostics, Inc.
12.11 QIAGEN N.V.
12.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
12.13 Siemens Healthineers AG
12.14 Thermo Fisher Scientific Inc.
12.15 Wama Diagnostica
12.16 Wiener Laboratorios SAIC
13. Appendix
13.1 Questionnaire
13.2 Available Customization
List of Tables
Table 1 Global In-Vitro Diagnostics (IVD) Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global In-Vitro Diagnostics (IVD) Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 4 Global In-Vitro Diagnostics (IVD) Reagents & Kits Market Size, by Country/Region, 2021–2030 (USD Million)
Table 5 Global In-Vitro Diagnostics (IVD) Software & Services Market Size, by Country/Region, 2021–2030 (USD Million)
Table 6 Global In-Vitro Diagnostics (IVD) Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 7 Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 8 Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay, by Country/Region, 2021–2030 (USD Million)
Table 9 Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay, by Type, 2021–2030 (USD Million)
Table 10 Global In-Vitro Diagnostics (IVD) Market Size for Enzyme-linked Immunosorbent Assays (ELISA), by Country/Region, 2021–2030 (USD Million)
Table 11 Global In-Vitro Diagnostics (IVD) Market Size for Radioimmunoassay, by Country/Region, 2021–2030 (USD Million)
Table 12 Global In-Vitro Diagnostics (IVD) Market Size for Western Blotting, by Country/Region, 2021–2030 (USD Million)
Table 13 Global In-Vitro Diagnostics (IVD) Market Size for Enzyme-linked Immunospot Assays, by Country/Region, 2021–2030 (USD Million)
Table 14 Global In-Vitro Diagnostics (IVD) Market Size for Immunohistochemistry (IHC), by Country/Region, 2021–2030 (USD Million)
Table 15 Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Country/Region, 2021–2030 (USD Million)
Table 16 Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 17 Global In-Vitro Diagnostics (IVD) Market Size for Metabolic Panel, by Country/Region, 2021–2030 (USD Million)
Table 18 Global In-Vitro Diagnostics (IVD) Market Size for Electrolyte Panel, by Country/Region, 2021–2030 (USD Million)
Table 19 Global In-Vitro Diagnostics (IVD) Market Size for Liver Panel, by Country/Region, 2021–2030 (USD Million)
Table 20 Global In-Vitro Diagnostics (IVD) Market Size for Lipid Profile, by Country/Region, 2021–2030 (USD Million)
Table 21 Global In-Vitro Diagnostics (IVD) Market Size for Renal Profile, by Country/Region, 2021–2030 (USD Million)
Table 22 Global In-Vitro Diagnostics (IVD) Market Size for Thyroid Function Panel, by Country/Region, 2021–2030 (USD Million)
Table 23 Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 24 Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 25 Global In-Vitro Diagnostics (IVD) Market Size for Polymerase Chain Reaction (PCR), by Country/Region, 2021–2030 (USD Million)
Table 26 Global In-Vitro Diagnostics (IVD) Market Size for Isothermal Nucleic Acid Amplification Technology, by Country/Region, 2021–2030 (USD Million)
Table 27 Global In-Vitro Diagnostics (IVD) Market Size for Microarray, by Country/Region, 2021–2030 (USD Million)
Table 28 Global In-Vitro Diagnostics (IVD) Market Size for Hybridization, by Country/Region, 2021–2030 (USD Million)
Table 29 Global In-Vitro Diagnostics (IVD) Market Size for DNA Sequencing & Next-generation Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 30 Global In-Vitro Diagnostics (IVD) Market Size for Mass Spectrometry, by Country/Region, 2021–2030 (USD Million)
Table 31 Global In-Vitro Diagnostics (IVD) Market Size for Others, by Country/Region, 2021–2030 (USD Million)
Table 32 Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 33 Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 34 Global In-Vitro Diagnostics (IVD) Market Size for Lateral Flow Assays/Rapid Tests, by Country/Region, 2021–2030 (USD Million)
Table 35 Global In-Vitro Diagnostics (IVD) Market Size for POC Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 36 Global In-Vitro Diagnostics (IVD) Market Size for Others, by Country/Region, 2021–2030 (USD Million)
Table 37 Global In-Vitro Diagnostics (IVD) Market Size for Whole Blood Glucose Monitoring, by Country/Region, 2021–2030 (USD Million)
Table 38 Global In-Vitro Diagnostics (IVD) Market Size for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 39 Global In-Vitro Diagnostics (IVD) Market Size for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 40 Global In-Vitro Diagnostics (IVD) Market Size for Coagulation/Hemostasis, by Country/Region, 2021–2030 (USD Million)
Table 41 Global In-Vitro Diagnostics (IVD) Market Size for Urinalysis, by Country/Region, 2021–2030 (USD Million)
Table 42 Global In-Vitro Diagnostics (IVD) Market Size for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 43 Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 44 Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 45 Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 46 Global In-Vitro Diagnostics (IVD) Market Size for Respiratory Infections, by Country/Region, 2021–2030 (USD Million)
Table 47 Global In-Vitro Diagnostics (IVD) Market Size for Hepatitis Testing, by Country/Region, 2021–2030 (USD Million)
Table 48 Global In-Vitro Diagnostics (IVD) Market Size for HIV Testing, by Country/Region, 2021–2030 (USD Million)
Table 49 Global In-Vitro Diagnostics (IVD) Market Size for Tropical Diseases Testing, by Country/Region, 2021–2030 (USD Million)
Table 50 Global In-Vitro Diagnostics (IVD) Market Size for Influenza, by Country/Region, 2021–2030 (USD Million)
Table 51 Global In-Vitro Diagnostics (IVD) Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2021–2030 (USD Million)
Table 52 Global In-Vitro Diagnostics (IVD) Market Size for Other Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 53 Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 54 Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 55 Global In-Vitro Diagnostics (IVD) Market Size for Breast Cancer, by Country/Region, 2021–2030 (USD Million)
Table 56 Global In-Vitro Diagnostics (IVD) Market Size for Lung Cancer, by Country/Region, 2021–2030 (USD Million)
Table 57 Global In-Vitro Diagnostics (IVD) Market Size for Colorectal and Gastrointestinal Cancer, by Country/Region, 2021–2030 (USD Million)
Table 58 Global In-Vitro Diagnostics (IVD) Market Size for Prostate Cancer, by Country/Region, 2021–2030 (USD Million)
Table 59 Global In-Vitro Diagnostics (IVD) Market Size for Other Cancers, by Country/Region, 2021–2030 (USD Million)
Table 60 Global In-Vitro Diagnostics (IVD) Market Size for Diabetes, by Country/Region, 2021–2030 (USD Million)
Table 61 Global In-Vitro Diagnostics (IVD) Market Size for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 62 Global In-Vitro Diagnostics (IVD) Market Size for Nephrology, by Country/Region, 2021–2030 (USD Million)
Table 63 Global In-Vitro Diagnostics (IVD) Market Size for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 64 Global In-Vitro Diagnostics (IVD) Market Size for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 65 Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 66 Global In-Vitro Diagnostics (IVD) Market Size for Lab Testing, by Country/Region, 2021–2030 (USD Million)
Table 67 Global In-Vitro Diagnostics (IVD) Market Size for OTC/Self-testing, by Country/Region, 2021–2030 (USD Million)
Table 68 Global In-Vitro Diagnostics (IVD) Market Size for Point of Care Testing, by Country/Region, 2021–2030 (USD Million)
Table 69 Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 70 Global In-Vitro Diagnostics (IVD) Market Size for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 71 Global In-Vitro Diagnostics (IVD) Market Size for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 72 Global In-Vitro Diagnostics (IVD) Market Size for Home Healthcare, by Country/Region, 2021–2030 (USD Million)
Table 73 Global In-Vitro Diagnostics (IVD) Market Size for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 74 Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 75 North America: Global In-Vitro Diagnostics (IVD) Market Size, by Country, 2021–2030 (USD Million)
Table 76 North America: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 77 North America: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 78 North America: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 79 North America: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 80 North America: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 81 North America: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 82 North America: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 83 North America: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 84 North America: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 85 North America: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 86 North America: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 87 U.S.: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 88 U.S.: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 89 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 90 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 91 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 92 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 93 U.S.: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 94 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 95 U.S.: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 96 U.S.: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 97 U.S.: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 98 Canada: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 99 Canada: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 100 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 101 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 102 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 103 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 104 Canada: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 105 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 106 Canada: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 107 Canada: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 108 Canada: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 109 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 110 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 111 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 112 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 113 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 114 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 115 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 116 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 117 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 118 Europe: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 119 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 120 Europe: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 121 Germany: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 122 Germany: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 123 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 124 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 125 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 126 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 127 Germany: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 128 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 129 Germany: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 130 Germany: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 131 Germany: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 132 France: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 133 France: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 134 France: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 135 France: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 136 France: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 137 France: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 138 France: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 139 France: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 140 France: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 141 France: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 142 France: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 143 U.K.: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 144 U.K.: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 145 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 146 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 147 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 148 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 149 U.K.: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 150 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 151 U.K.: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 152 U.K.: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 153 U.K.: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 154 Italy: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 155 Italy: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 156 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 157 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 158 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 159 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 160 Italy: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 161 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 162 Italy: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 163 Italy: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 164 Italy: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 165 Spain: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 166 Spain: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 167 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 168 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 169 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 170 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 171 Spain: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 172 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 173 Spain: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 174 Spain: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 175 Spain: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 176 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 177 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 178 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 179 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 180 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 181 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 182 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 183 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 184 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 185 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 186 Switzerland: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 187 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 188 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 189 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 190 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 191 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 192 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 193 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 194 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 195 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 196 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 197 Rest of Europe: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 198 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 199 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 200 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 201 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 202 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 203 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 204 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 205 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 206 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 207 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 208 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 209 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 210 Japan: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 211 Japan: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 212 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 213 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 214 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 215 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 216 Japan: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 217 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 218 Japan: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 219 Japan: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 220 Japan: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 221 China: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 222 China: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 223 China: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 224 China: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 225 China: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 226 China: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 227 China: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 228 China: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 229 China: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 230 China: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 231 China: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 232 India: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 233 India: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 234 India: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 235 India: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 236 India: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 237 India: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 238 India: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 239 India: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 240 India: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 241 India: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 242 India: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 243 Australia: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 244 Australia: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 245 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 246 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 247 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 248 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 249 Australia: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 250 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 251 Australia: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 252 Australia: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 253 Australia: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 254 South Korea: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 255 South Korea: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 256 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 257 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 258 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 259 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 260 South Korea: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 261 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 262 South Korea: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 263 South Korea: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 264 South Korea: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 265 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 266 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 267 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 268 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 269 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 270 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 271 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 272 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 273 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 274 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 275 Rest of Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 276 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 277 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 278 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 279 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 280 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 281 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 282 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 283 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 284 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 285 Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 286 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 287 Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 288 Brazil: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 289 Brazil: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 290 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 291 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 292 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 293 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 294 Brazil: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 295 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 296 Brazil: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 297 Brazil: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 298 Brazil: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 299 Mexico: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 300 Mexico: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 301 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 302 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 303 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 304 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 305 Mexico: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 306 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 307 Mexico: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 308 Mexico: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 309 Mexico: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 310 Argentina: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 311 Argentina: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 312 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 313 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 314 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 315 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 316 Argentina: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 317 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 318 Argentina: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 319 Argentina: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 320 Argentina: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 321 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 322 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 323 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 324 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 325 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 326 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 327 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 328 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 329 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 330 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 331 Rest of Latin America: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 332 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 333 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 334 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 335 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 336 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 337 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 338 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 339 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 340 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 341 Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 342 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 343 Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 344 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 345 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 346 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 347 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 348 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 349 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 350 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 351 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 352 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 353 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 354 Saudi Arabia: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 355 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 356 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 357 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 358 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 359 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 360 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 361 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 362 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 363 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 364 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 365 Rest of Middle East: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 366 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 367 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 368 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 369 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 370 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 371 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 372 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 373 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 374 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 375 Africa: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 376 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 377 Africa: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 378 South Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 379 South Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 380 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 381 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 382 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 383 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 384 South Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 385 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 386 South Africa: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 387 South Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 388 South Africa: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 389 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2021–2030 (USD Million)
Table 390 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2021–2030 (USD Million)
Table 391 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Immunoassay/Immunochemistry, by Type, 2021–2030 (USD Million)
Table 392 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Biochemistry/Clinical Chemistry, by Type, 2021–2030 (USD Million)
Table 393 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Molecular Diagnostics, by Type, 2021–2030 (USD Million)
Table 394 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Point of Care (POC) Diagnostics, by Type, 2021–2030 (USD Million)
Table 395 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2021–2030 (USD Million)
Table 396 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 397 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 398 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2021–2030 (USD Million)
Table 399 Rest of Africa: Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2021–2030 (USD Million)
Table 400 Recent Developments, by Company, 2020–2022
List of Figure
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2023 VS. 2030 (USD Million)
Figure 7 Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2023 VS. 2030 (USD Million)
Figure 8 Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2023 VS. 2030 (USD Million)
Figure 9 Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2023 VS. 2030 (USD Million)
Figure 10 Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2023 VS. 2030 (USD Million)
Figure 11 Global In-Vitro Diagnostics (IVD) Market Size, by Geography
Figure 12 Market Dynamics
Figure 13 Global In-Vitro Diagnostics (IVD) Market Size, by Product & Solution, 2023–2030 (USD Million)
Figure 14 Global In-Vitro Diagnostics (IVD) Market Size, by Technology, 2023–2030 (USD Million)
Figure 15 Global In-Vitro Diagnostics (IVD) Market Size, by Application, 2023–2030 (USD Million)
Figure 16 Global In-Vitro Diagnostics (IVD) Market Size, by Diagnostic Approach, 2023–2030 (USD Million)
Figure 17 Global In-Vitro Diagnostics (IVD) Market Size, by End User, 2023–2030 (USD Million)
Figure 18 Global In-Vitro Diagnostics (IVD) Market Size, by Region, 2023–2030 (USD Million)
Figure 19 North America: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 20 Europe: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 21 Asia-Pacific: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 22 Latin America: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 23 Middle East: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 24 Africa: Global In-Vitro Diagnostics (IVD) Market Snapshot
Figure 25 Key Growth Strategies Adopted by Leading Players (2020–2022)
Figure 26 Global In-Vitro Diagnostics (IVD) Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Global In-Vitro Diagnostics (IVD) Market (2022)
Figure 28 Abbott Laboratories: Financial Overview (2021)
Figure 29 Becton, Dickinson and Company: Financial Overview (2021)
Figure 30 bioMérieux SA: Financial Overview (2021)
Figure 31 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 32 Danaher Corporation: Financial Overview (2021)
Figure 33 F. Hoffmann-La Roche Ltd.: Financial Overview (2021)
Figure 34 Illumina, Inc.: Financial Overview (2021)
Figure 35 QIAGEN N.V.: Financial Overview (2021)
Figure 36 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Financial Overview (2021)
Figure 37 Siemens Healthineers AG: Financial Overview (2021)
Figure 38 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 39 Agilent Technologies Inc.: Financial Overview (2021)
Figure 40 DiaSorin S.p.A.: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Jan-2023
Published Date: Nov-2022
